Study Group | Sevofluranea (n = 91) | Desfluranea (n = 92) | p-value |
ED incidence | 24/91 (26.4%) | 15/92 (16.3%) | 0.185 |
PAED Score (5 min) | 4.2 ± 5.5 | 3.7 ± 4.4 | 0.468 |
PAED Score (15 min) | 2.8 ± 4.1 | 2.01 ± 3.6 | 0.150 |
Patients needing midazolam for ED management | 5/9 (56%) | 4/9 (44%) | 0.637 |